Cattle healthcare is an important part of animal husbandry, as productivity is dependent on health of cattle. Cattle healthcare focuses on the treatment and diagnosis of cattle, and ensure the optimal care and well-being of dairy cattle and reduce losses in the productivity caused by the disease. It is critically important for the control of infectious diseases in beef and dairy cattle. Veterinarian plays an important role in preventing, diagnosing, and treating animal diseases.
Market Statistics:
The Global Cattle Healthcare Market is estimated to account for US$ 8,369.5 Mn in terms of value by the end of 2022.
Drivers:
Increase in burden of animal disease or increase in prevalence of infectious diseases in cattle is expected to propel the growth of the global cattle healthcare market during the forecast period. For instance, Lumpy Skin Disease is a viral outbreak that targets cattle. Starting from the outbreak in Gujarat and Rajasthan, in three months cattle in 15 states across India were affected. According to the Government of India, Lumpy has already infected over 2.4 million animals and has led to over 110,000 cattle deaths in India. The 2022 lumpy skin disease outbreak in India resulted in the death of over 97,000 cattle in three months between July and 23 September.
Opportunities:
Growing focus on cattle health and involvement of the government and favorable initiatives are expected to offer significant growth opportunities for players in the global cattle healthcare market. For instance, in February 2020, FORTE Healthcare Limited announced the launch of PROCAPEN Injector 3g Intramammary Suspension for cattle, a prescription intramammary for the treatment of udder infections in lactating cows. PROCAPEN contains high dose of Procaine Benzyl Penicillin, which is the drug of choice against benzylpenicillin-susceptible streptococci and staphlococci. It is an antibiotic, targeting the most important pathogens in fresh cases of mastitis in cows.
Restraints:
High cost of animal testing & veterinary services, lack of infrastructure, and regulatory challenges are some major factors expected to hamper the growth of the global cattle healthcare market over the forecast period. For instance, some animal tests take months or years to conduct and analyze, at the cost of hundreds of thousands, sometimes millions of dollars. Moreover, most developing countries have inadequate animal healthcare infrastructure, insufficient storage capacity (for drugs & vaccines), and poor connectivity. The aforementioned factors along with insufficient funding is restraining the growth of the cattle healthcare market.
Global Cattle Healthcare Market - Impact of Coronavirus (Covid-19) Pandemic:
The outbreak of COVID-19 and subsequent economic crisis has had a severe impact on the control of diseases that are already present across the globe. Governments around the world are focusing on preventing and responding to new and emerging animal diseases in a timely manner. However, the emergence of novel disease, such as 2022 lumpy skin disease outbreak in India, has increased or increase in demand for cattle healthcare. Starting from the outbreak in Gujarat and Rajasthan, in three months cattle in 15 states across India were affected. This in turn is expected to aid in the growth of the market, especially in India.
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/cattle-healthcare-market-5347
Key Takeaways:
The global cattle healthcare market was valued at US$ 7,882.4 Mn in 2021 and is forecast to reach a value of US$ 12,041.3 Mn by 2028 at a CAGR of 6.2% between 2022 and 2028.
Among product type Vaccines segment held dominant position in the global cattle healthcare market in 2021, accounting for 36.1% share in terms of value, increasing approval and launch of new products is expected to propel growth of the segment during the forecast period.
Market Trends:
There is an increase in demand for vaccination across the globe due to increase in burden of animal diseases, such as Lumpy (viral disease of cattle). Proper vaccination is critically important for the control of infectious diseases in both beef and dairy cattle. Vaccination plays an important role in cattle health management. This trend is expected to continue over the forecast period, driving the growth of the global cattle healthcare market.
Competitive Landscape:
Major players operating in the global cattle healthcare market include Boehringer Ingelheim, Idexx Laboratories, Virbac, Elanco, IDVet, Zoetis Inc., Bayer Healthcare, Merck & Co. Inc., and Ceva Animal Health Inc., among others.
Recent Developments:
In April 2018, Zoetis announced plans to expand its animal vaccine research and manufacturing in Suzhou, China. The new facility will focus on development and production of quality vaccines for swine, cattle, fish, and companion animals that will help protect against the strains of diseases prevalent in China.
In December 2017, Zoetis Inc. Launched Vanguard CIV H3N2/H3N8 vaccine for canine influenza virus. The new bivalent vaccine helps protect dogs against the two strains of the virus.
